← Insider Monitor
BLSM
BlossomHill Therapeutics, Inc.
Recent activity from public SEC and congressional filings.
7
Insider trades
0
Congress trades
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Schmid John P.Insider | Buy | $96K | 6,000at $16.00 | Aug 10, 2026 |
| ORBIMED ADVISORS LLCDirector | Buy | $10.00M | 625,000at $16.00 | Aug 10, 2026 |
| GORDON CARL LDirector | Buy | $10.00M | 625,000at $16.00 | Aug 10, 2026 |
| Keyes Jason AChief Financial Officer | Buy | $11K | 700at $16.00 | Aug 10, 2026 |
| Liptak Vincent PaulGeneral Counsel | Buy | $35K | 2,200at $16.00 | Aug 10, 2026 |
| Liptak Vincent PaulGeneral Counsel | Buy | $40K | 2,500at $15.80 | Aug 7, 2026 |
| Chen BihuaInsider | Buy | $5.00M | 312,500at $16.00 | Aug 10, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
No recent congressional disclosures found for BLSM.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable BLSM activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.